Granulocyte-Macrophage Colony Stimulating Factor: An Adjuvant for Cancer Vaccines

References

• Houghton, A.N. (1994) "Cancer antigens: immune recog-nition of self and altered self", J. Exp. Med. 180, 1–4.
   PubMed Web of Science ®Google Scholar
• Perales, M.A., Blachere, N.E., Engelhorn, M.E., Ferrone, CR., Gold, J.S., Gregor, P.D., Noffz, G., Wolchok, J.D. and Houghton, A.N. (2002) "Strategies to overcome immune ignorance and tolerance", Semin. Cancer Biol. 12, 63–71.
   PubMed Web of Science ®Google Scholar
• Armitage, JD. (1998) "Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor", Blood 92, 4491–4508.
   PubMed Web of Science ®Google Scholar
• Kaplan, G., Walsh, G., Guido, L.S., Meyn, P., Burkhardt, R.A., Abalos, R.M., Barker, J., Frindt, PA., Fajardo, T.T., Celona, R., et al. (1992) "Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing", J. Exp. Med. 175, 1717–1728.
   PubMed Web of Science ®Google Scholar
• Nasi, ML., Lieberman, P., Busam, K.J., Prieto, V, Panageas, KS., Lewis, J.J., Houghton, A.N. and Chapman, P.B. (1999) "Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells", Cytokines Cell. MoL Ther. 5, 139–144.
   PubMedGoogle Scholar
• Wang, J., Snider, D.P., Hewlett, BR., Lukacs, NW., Gauldie, J., Liang, H. and Xing, Z. (2000) "Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung", Blood 95, 2337–2345.
   PubMed Web of Science ®Google Scholar
• Xing, Z., Gauldie, J., Tremblay, G.M., Hewlett, B.R. and Addison, C. (1997) "Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans' cell/ macrophage accumulation, and dermal fibrosis", Lab. Investig. 77, 615–622.
   PubMed Web of Science ®Google Scholar
• Fischer, HG., Frosch, S., Reske, K. and Reske-Kunz, A.B. (1988) "Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function", J. Immunol. 141, 3882–3888.
   PubMed Web of Science ®Google Scholar
• Chang, C.H., Furue, M. and Tamaki, K. (1995) "B7-1 expression of Langerhans cells is up-regulated by pro-inflammatory cytokines, and is down-regulated by interferon-gamma or by interleuldn-10", Fur. J. Immunol. 25, 394–398.
   Web of Science ®Google Scholar
• Spitler, L.E., Grossbard, ML., Ernstoff, MS., Silver, G., Jacobs, M., Hayes, F.A. and Soong, S.J. (2000) "Adjuvant therapy of stage ifi and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor", J. Clin. Oncol. 18, 1614–1621.
   PubMed Web of Science ®Google Scholar
• Chang, D.H. and Dhodapkar, M.V. (2003) "Dendritic cells and immunotherapy for cancer", Int. J. Hematol. 77, 439–443.
   PubMed Web of Science ®Google Scholar
• Buchler, T., Michalek, J., Kovarova, L., Musilova, R. and Hajek, R. (2003) "Dendritic cell-based immunotherapy for the treatment of hematological malignancies", Hematology 8, 97–104.
   PubMedGoogle Scholar
• Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. and Mulligan, R.C. (1993) "Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity", Proc. Natl Acad. Sci. USA 90, 3539–3543.
   PubMed Web of Science ®Google Scholar
• Kielian, T., Nagai, E., likubo, A., Rasmussen, C.A. and Suzuld, T. (1999) "Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1alpha and accumulation of dendritic cells at vaccination sites in vivo", Cancer Immunol. Immunot her. 48, 123–131.
   PubMed Web of Science ®Google Scholar
• Shinohara, H., Yano, S., Bucana, CD. and Fidler, I.J. (2000) "Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells", J. Immunol. 164, 2728–2737.
   PubMed Web of Science ®Google Scholar
• Sanda, M.G., Ayyagari, S.R. Jaffee, E.M., Epstein, J.I., Clift, S .L., Cohen, L.K., Dranoff, G., Pardoll, D.M., Mulligan, R.C. and Simons, J.W. (1994) "Demonstration of a rational strategy for human prostate cancer gene therapy", J. Urol. 151, 622–628.
   PubMed Web of Science ®Google Scholar
• Dunussi-Joannopoulos, K., Dranoff, G., Weinstein, H.J., Ferrara, J.L., Bierer, B.E. and Croop, J.M. (1998) "Gene immunotherapy in murine acute myeloid leukemia: granulo-cyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines", Blood 91, 222–230.
   PubMed Web of Science ®Google Scholar
• Levitsky, HI., Montgomery, J., Ahmadzadeh, M., Staveley-O'Carroll, K., Guarnieri, F., Longo, D.L. and Kwak, L.W. (1996) "Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity", J. Immunol. 156, 3858–3865.
   PubMed Web of Science ®Google Scholar
• Ellem, K.A., O'Rourke, `, Johnson, G.R., Parry, G., Misko, IS., Schmidt, C.W., Parsons, E.G., Burrows, SR., Cross, S., Fell, A., Li, C.L., Bell, J.R., Dubois, P.J., Moss, D.J., Good, M.F., Kelso, A., Cohen, L.K., Dranoff, G. and Mulligan, R.C. (1997) "A case report: immune responses and clinical course of the first human use of granulocyte/ macrophage-colony-stimulating-factor-transduced auto-logous melanoma cells for immunotherapy", Cancer Immunol. Immunother. 44, 10–20.
   PubMed Web of Science ®Google Scholar
• Dranoff, G., Soiffer, R., Lynch, T., Mihm, M., Jung, K., Kolesar, K., Liebster, L., Lam, P., Duda, R., Mentzer, S., Singer, S., Tanabe, K., Johnson, R., Sober, A., Bhan, A., Clift, S., Cohen, L., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A. and Mulligan, R.C. (1997) "A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor", Hum. Gene Ther. 8, 111–123.
   PubMed Web of Science ®Google Scholar
• Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J.C., Hodi, F.S., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K.K., Cosimi, A.B., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Dranoff, G., et al. (1998) "Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma", Proc. Natl Acad. Sci. USA 95, 13141–13146.
   PubMed Web of Science ®Google Scholar
• Chang, A.E., Li, Q., Bishop, D.K., Normolle, D.P., Redman, B.D. and Nickoloff, B.J. (2000) "Immunogenetic therapy of human melanoma utilizing autologous tumor cells trans-duced to secrete granulocyte-macrophage colony-stimulating factor", Hum. Gene Ther. 11, 839–850.
   PubMed Web of Science ®Google Scholar
• Soiffer, R., Hodi, F.S., Haluska, E, Jung, K., Gillessen, S., Singer, S., Tanabe, K., Duda, R., Mentzer, S., Jaklitsch, M., Bueno, R., Clift, S., Hardy, S., Neuberg, D., Mulligan, R., Webb, I., Mihm, M. and Dranoff, G. (2003) "Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adeno-viral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma", J. Clin. Oncol. 21, 3343–3350.
   PubMed Web of Science ®Google Scholar
• Simons, J.W. (1997) "Bioactivity of human GM-CSF gene therapy in metastatic renal cell carcinoma and prostate cancer", Hinyokika Kiyo 43, 821–822.
   PubMedGoogle Scholar
• Simons, J.W., Mikhak, B., Chang, J.F., DeMarzo, A.M., Carducci, M.A., Lim, M., Weber, C.E., Baccala, A.A., Goemarm, M.A., Clift, S.M., Ando, D.G., Levitsky, Cohen, L.K., Sanda, M.G., Mulligan, R.C., Partin, A.VV., Carter, H.B., Piantadosi, S., Marshall, EE and Nelson, W.G. (1999) "Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer", Cancer Res. 59,5160–5168.
   PubMed Web of Science ®Google Scholar
• Wittig, B., Marten, A., Dorbic, T., Weineck, S., Min, H., Niemitz, S., Trojaneck, B., Flieger, D., Kruopis, S., Albers, A., Loffel, J., Neubauer, A., Albers, P., Muller, S., Sauerbruch, T., Bieber, T., Huhn, D. and Schmidt-Wolf, I.G. (2001) "Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase VII trial", Hum. Gene Ther. 12, 267–278.
   PubMed Web of Science ®Google Scholar
• Jaffee, E.M., Dranoff, G., Cohen, L.K., Hauda, K.M., Clift, S., Marshall, FF., Mulligan, R.C. and Pardoll, D.M. (1993) "High efficiency gene transfer into primary human tumor explants without cell selection", Cancer Res. 53, 2221–2226.
   PubMed Web of Science ®Google Scholar
• Borrello, I., Sotomayor, E.M., Cooke, S. and Levitsky, H.I. (1999) "A universal granulocyte-macrophage colony-stimu-lating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines", Hum. Gene Ther. 10, 1983–1991.
   PubMed Web of Science ®Google Scholar
• Overwijk, W.W., Lee, D.S., Surman, D.R., Irvine, K.R., Touloukian, C.E., Chan, C.C., Carroll, M.W., Moss, B., Rosenberg, S.A. and Restifo, N.P. (1999) "Vaccination with a recombinant vaccinia virus encoding a self antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4(+ ) T lymphocytes", Proc. Natl Acad. Sci. USA 96, 2982–2987.
   PubMed Web of Science ®Google Scholar
• Bronte, V, Apolloni, E., Ronca, R., Zamboni, E, Overwijk, W.W., Surman, D.R., Restifo, N.P. and Zanovello, P. (2000) "Genetic vaccination with 'self' tyrosinase-related protein 2 causes melanoma eradication but not vitiligo", Cancer Res. 60, 253–258.
   PubMed Web of Science ®Google Scholar
• Irvine, K.R., Chamberlain, R.S., Shulman, E.P., Rosenberg, S.A. and Restifo, N.P. (1997) "Route of immunization and the therapeutic impact of recombinant anticancer vaccines", J. Natl Cancer Inst. 89, 390–392.
   PubMed Web of Science ®Google Scholar
• Hirschowitz, E.A., Leonard, S., Song, W., Ferris, B., Leopold, P.L., Lewis, J.J., Bowne, W.B., Wang, S., Houghton, A.N. and Crystal, R.G. (1998) "Adenovirus-mediated expression of melanoma antigen gp75 as immuno-therapy for metastatic melanoma", Gene Ther. 5, 975–983.
   PubMed Web of Science ®Google Scholar
• Rosenberg, S.A., Zhai, Y., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, EM., Topalian, S.L., Restifo, N.P., Seipp, CA., Einhorn, J.H., Roberts, B. and White, D.E. (1998) "Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens", J. Natl Cancer Inst. 90, 1894–1900.
   PubMed Web of Science ®Google Scholar
• Qin, H. and Chatterjee, S.K. (1996) "Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF", Hum. Gene Ther. 7, 1853–1860.
   PubMed Web of Science ®Google Scholar
• Kass, E., Parker, J., Schlom, J. and Greiner, J.W. (2000) "Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes", Cytokine 12, 960–971.
   PubMed Web of Science ®Google Scholar
• von Mehren, M., Arlen, P., Gulley, J., Rogatko, A., Cooper, H.S., Meropol, N.J., Alpaugh, R.K., Davey, M., McLaughlin, S., Beard, UT., Tsang, KY, Schlom, J. and Weiner, L.M. (2001) "The influence of granulocyte macro-phage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma", Clin. Cancer Res. 7, 1181–1191.
   PubMed Web of Science ®Google Scholar
• Ullenhag, G.J., Frodin, J.E., Mosolits, S., Kiaii, S., Hassan, M., Bonnet, MC., Moingeon, P., Mellstedt, H. and Rabbani, H. (2003) "Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune response", Clin. Cancer Res. 9, 2447–2456.
   PubMed Web of Science ®Google Scholar
• Weber, J.S., Hua, EL., Spears, L., Marty, V, Kuniyoshi, C. and Celis, E. (1999) "A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma", J. Immunot her. 22, 431–440.
   PubMed Web of Science ®Google Scholar
• Marchand, M., van Baren, N., Weynants, P., Brichard, V, Dreno, B., Tessier, M.H., Rankin, E., Parmiani, G., Arienti, E, Humblet, Y., Bourlond, A., Vanwijck, R., Lienard, D., Beauduin, M., Dietrich, P.Y., Russo, V, Kerger, J., Masucci, G., Jager, E., De Greve, J., Atzpodien, J., Brasseur, E, Coulie, E.G., van der Bruggen, P. and Boon, T. (1999) "Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1", Int. J. Cancer 80, 219–230.
   PubMed Web of Science ®Google Scholar
• Jaeger, E., Bernhard, H., Romero, P., Ringhoffer, M., Arand, M., Karbach, J., llsemarm, C., Hagedorn, M. and Knuth, A. (1996) "Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens", Int. J. Cancer 66, 162–169.
   PubMed Web of Science ®Google Scholar
• Jager, E., Ringhoffer, M., Dienes, H.P., Arand, M., Karbach, J., Jager, D., llsemann, C., Hagedorn, M., Oesch, F. and Knuth, A. (1996) "Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated pep-tides in vivo", Int. J. Cancer 67, 54–62.
   PubMed Web of Science ®Google Scholar
• Salgaller, M.L., Marincola, F.M., Cormier, J.N. and Rosenberg, S.A. (1996) "Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides", Cancer Res. 56, 4749–4757.
   PubMed Web of Science ®Google Scholar
• Cormier, J.N., Salgaller, M.L., Prevette, T., Barracchini, K.C., Rivoltini, L., Restifo, NP, Rosenberg, S.A. and Marincola, F.M. (1997) "Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1 /Melan A", Cancer J. Sci. Am. 3, 37–44.
   PubMed Web of Science ®Google Scholar
• Rosenberg, S.A., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, F.M., Topalian, S.L., Restifo, N.P., Dudley, M.E., Schwarz, S.L., Spiess, P.J., Wunderlich, J.R., Parkhurst, M.R., Kawakami, Y., Seipp, CA., Einhorn, J.H. and White, D.E. (1998) "Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma", Nat. Med. 4, 321–327.
   PubMed Web of Science ®Google Scholar
• Lee, K.H., Wang, E., Nielsen, M.B., Wunderlich, J., Migueles, S., Connors, M., Steinberg, S.M., Rosenberg, S.A. and Marincola, F.M. (1999) "Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased suscepti-bility to in vitro stimulation but does not lead to tumor regression", J. Immunol. 163, 6292–6300.
   PubMed Web of Science ®Google Scholar
• Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S. and Weber, J. (1999) "Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma", Clin. Cancer Res. 5,2756–2765.
   PubMed Web of Science ®Google Scholar
• Lewis, J.J., Janetzld, S., Schaed, S., Panageas, KS., Wang, S., Williams, L., Meyers, M., Butterworth, L., Livingston, P.O., Chapman, P.B. and Houghton, A.N. (2000) "Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide", Int. J. Cancer 87, 391–398.
   PubMed Web of Science ®Google Scholar
• Scheibenbogen, C., Schmittel, A., Keilholz, U., Allgauer, T., Hofmann, U., Max, R., Thiel, E. and Schadendorf, D. (2000) "Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma", J. Immunother. 23, 275–281.
   PubMed Web of Science ®Google Scholar
• Lee, P., Wang, F., Kuniyoshi, J., Rubio, V., Stages, T., Groshen, S., Gee, C., Lau, R. Jeffery, G., Margolin, K., Marty, V. and Weber, J. (2001) "Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma", J. Clin. Oncol. 19,3836–3847.
   Web of Science ®Google Scholar
• Jager, E., Hohn, H., Necker, A., Forster, R, Karbach, J., Freitag, K., Neuldrch, C., Castelli, C., Salter, RD., Knuth, A. and Maeurer, M.J. (2002) "Peptide-specific CD8 + T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1", Int. J. Cancer 98, 376–388.
   PubMed Web of Science ®Google Scholar
• Schaed, S.C., Klimek, V.M., Panageas, KS., Musselli, C.M., Butterworth, L., Hwu, W.J., Livingston, P.O., Williams, L., Lewis, J.J., Houghton, A.N. and Chapman, P.B. (2002) "T-cell responses against tyrosinase 368-376(370D) peptide in HLA(*)A0201(+) melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants", Clin. Cancer Res. 8, 967–972.
   PubMed Web of Science ®Google Scholar
• Scheibenbogen, C., Schadendorf, D., Bechrakis, N.E., Nagorsen, D., Hofmann, U., Servetopoulou, F., Letsch, A., Philipp, A., Foerster, M.H., Schmittel, A., Thiel, E. and Keilholz, U. (2003) "Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides", Int. J. Cancer 104, 188–194.
   PubMed Web of Science ®Google Scholar
• Parkhurst, M.R., Salgaller, M.L., Southwood, S., Robbins, P.F., Sette, A., Rosenberg, S.A. and Kawakami, Y. (1996) "Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues", J. Immunol. 157, 2539–2548.
   PubMed Web of Science ®Google Scholar
• Dyall, R., Bowne, W.B., Weber, LW., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J.J., Houghton, A.N. and Nikolic-Zugic, J. (1998) "Heteroclitic immunization induces tumor immunity", J. Exp. Med. 188, 1553–1561.
   PubMed Web of Science ®Google Scholar
• Slansky, E.J., Rattis, M.F., Boyd, F.L., Fahmy, T., Jaffee, M.E., Schneck, P.J., Margulies, H.D. and Pardoll, M.D. (2000) "Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR com-plex", Immunity 13, 529–538.
   PubMed Web of Science ®Google Scholar
• Smith, 2nd, J.W., Walker, E.B., Fox, B.A., Haley, D., Wisner, K.P., Doran, T., Fisher, B., Justice, L., Wood, W., Vetto, J., Maecker, H., Dols, A., Meijer, S., Hu, H.M., Romero, P., Alvord, W.G. and Urba, W.J. (2003) "Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses", J. Clin. Oncol. 21, 1562–1573.
   PubMed Web of Science ®Google Scholar
• Weber, J., Sondak, V.K., Scotland, R., Phillip, R., Wang, F., Rubio, V, Stuge, T.B., Groshen, S.C., Gee, C., Jeffery, C.C., Sian, S. and Lee, P.P. (2003) "Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage 11 melanoma", Cancer 97, 186–200.
   PubMed Web of Science ®Google Scholar
• Weeratna, R.D., McClusIde, M.J., Xu, Y. and Davis, H.L. (2000) "CpG DNA induces stronger immune responses with less toxicity than other adjuvants", Vaccine 18, 1755–1762.
   PubMed Web of Science ®Google Scholar
• Disis, ML., Grabstein, K.H., Sleath, P.R. and Cheever, M.A. (1999) "Generation of immunity to the HER-2 /neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine", Clin. Cancer Res. 5, 1289–1297.
   PubMed Web of Science ®Google Scholar
• Kwak, LW., Young, HA., Pennington, R.W. and Weeks, S.D. (1996) "Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/ macrophage colony-stimulating factor primes mice for a protective T-cell response", Proc. Natl Acad. Sci. USA 93, 10972–10977.
   PubMed Web of Science ®Google Scholar
• Timmerman, J.M. and Levy, R. (2000) "Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine", J. Immunol. 164, 4797–4803.
   PubMed Web of Science ®Google Scholar
• Pasquini, S., Peralta, S., Missiaglia, E., Carta, L. and Lemoine, N.R. (2002) "Prime-boost vaccines encoding an intracellular idiotype/GM-CSF fusion protein induce protective cell-mediated immunity in murine pre-B cell leukemia", Gene Ther. 9, 503–510.
   PubMed Web of Science ®Google Scholar
• Porgador, A., Irvine, KR., Iwasaki, A., Barber, B.H., Restifo, NY. and Germain, RN. (1998) "Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization", J. Exp. Med. 188, 1075–1082.
   PubMed Web of Science ®Google Scholar
• Casares, S., Inaba, K., Brumeanu, T.D., Steinman, R.M. and Bona, C.A. (1997) "Antigen presentation by dendritic cells after immunization with DNA encoding a major histo-compatibility complex class II-restricted viral epitope", J. Exp. Med. 186, 1481–1486.
   PubMed Web of Science ®Google Scholar
• Akbari, O., Panjwani, N., Garcia, S., Tascon, R., Lowrie, D. and Stockinger, B. (1999) "DNA vaccination: transfection and activation of dendritic cells as key events for immunity", J. Exp. Med. 189, 169–178.
   PubMed Web of Science ®Google Scholar
• Klinman, D.M., Yi, AK., Beaucage, S.L., Conover, J. and Krieg, A.M. (1996) "CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, inter-leuldn 12, and interferon gamma", Proc. Natl Acad. Sci. USA 93, 2879–2883.
   PubMed Web of Science ®Google Scholar
• Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.D., Silverman, G.J., Lotz, M., Carson, D.A. and Raz, E. (1996) "Immunostimulatory DNA sequences necessary for effective intradermal gene immunization", Science 273, 352–354.
   PubMed Web of Science ®Google Scholar
• Wang, R., Doolan, D.L., Le, T.P., Hedstrom, R.C., Coonan, K.M., Charoenvit, Y., Jones, T.R., Hobart, P., Margalith, M., Ng, J., Weiss, W.R., Sedegah, M., de Taisne, C., Norman, J.A. and Hoffman, S.L. (1998) "Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine", Science 282, 476–480.
   PubMed Web of Science ®Google Scholar
• Boyer, J.D., Cohen, A.D., Vogt, S., Schumann, K., Nath, B., Aim, L., Lacy, K., Bagarazzi, M.L., Higgins, T.J., Baine, Y., Ciccarelli, R.B., Ginsberg, R.S., MacGregor, R.R. and Weiner, D.B. (2000) "Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lympho-cyte production of beta-chemokines", J. Infect Dis. 181, 476–483.
   PubMed Web of Science ®Google Scholar
• Ugen, K.E., Nyland, S.B., Boyer, J.D., Vidal, C., Lera, L., Rasheid, S., Chattergoon, M., Bagarazzi, ML., Ciccarelli, R., Higgins, T., Baine, Y., Ginsberg, R., Macgregor, R.R. and Weiner, D.B. (1998) "DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans", Vaccine 16, 1818–1821.
   PubMed Web of Science ®Google Scholar
• Weber, L.W., Bowne, W.B., Wolchok, J.D., Srinivasan, R., Qin, J., Moroi, Y., Clynes, R., Song, P., Lewis, J.J. and Houghton, A.N. (1998) "Tumor immunity and autoimmunity induced by immunization with homologous DNA", J. Clin. Invest. 102, 1258–1264.
   PubMed Web of Science ®Google Scholar
• Bowne, W.B., Srinivasan, R., Wolchok, J.D., Hawkins, W.G., Blachere, N.E., Dyall, R., Lewis, J.J. and Houghton, A.N. (1999) "Coupling and uncoupling of tumor immunity and autoimmunity", J. Exp. Med. 190, 1717–1722.
   PubMed Web of Science ®Google Scholar
• Hawkins, W.G., Gold, J.S., Dyall, R., Wolchok, J.D., Hoos, A., Bowne, W.B., Srinivasan, R., Houghton, A.N. and Lewis, J.J. (2000) "Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity", Surgery 128, 273–280.
   PubMed Web of Science ®Google Scholar
• Bergman, P.J., McKnight, J., Novosad, A., Charney, S., Farrelly, J., Craft, D., Wulderk, M., Jeffers, Y., Sadelain, M., Hohenhaus, A.E., Segal, N., Gregor, P., Engelhorn, M., Riviere, I., Houghton, A.N. and Wolchok, J.D. (2003) "Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial", Clin. Cancer Res. 9, 1284–1290.
   PubMed Web of Science ®Google Scholar
• Disis, M.L., Shiota, F.M., McNeel, D.G. and Knutson, K.L. (2003) "Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens", Immunobiology 207, 179–186.
   PubMed Web of Science ®Google Scholar
• Weiss, W.R., Ishii, K.J., Hedstrom, R.C., Sedegah, M., Ichino, M., Barnhart, K., Klinman, D.M. and Hoffman, S.L. (1998) "A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine", J. Immunol. 161,2325–2332.
   PubMed Web of Science ®Google Scholar
• Raviprakash, K., Ewing, D., Simmons, M., Porter, K.R., Jones, T.R., Hayes, C.G., Stout, R. and Murphy, G.S. (2003) "Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys", Virology 315, 345–352.
   PubMed Web of Science ®Google Scholar
• Bowne, W.B., Wolchok, J.D., Hawkins, W.G., Srinivasan, R., Gregor, P., Blachere, N.E., Moroi, Y., Engelhorn, M.E., Houghton, A.N. and Lewis, J.J. (1999) "Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects", Cytokines Cell. Mol. Ther. 5, 217–225.
   PubMedGoogle Scholar
• Sun, X., Hodge, L.M., Jones, H.P., Tabor, L. and Simecka, J.W. (2002) "C o- expre s si on of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination", Vaccine 20, 1466–1474.
   PubMed Web of Science ®Google Scholar
• Perales, M.A., Fantuzzi, G., Goldberg, S.M., Turk, M.J., Mortazavi, F., Busam, K., Houghton, A.N., Dinarello, C.A. and Wolchok, J.D. (2002) "GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: impli-cations for DNA vaccines", Cytokines Cell. Mol. Ther. 7, 125–133.
   PubMed Web of Science ®Google Scholar
• Muller, C.E., Mukodzi, S. and Reddemann, H. (1999) "Relationships of cytokine (GM-CSF) serum concentration to blood cell count and the inflammatory parameters in children with malignant diseases", Pediatr. Hematol. Oncol. 16, 509–518.
   PubMed Web of Science ®Google Scholar
• Timmerman, J.M., Singh, G., Hermanson, G., Hobart, P., Czerwinski, D.K., Taidi, B., Rajapaksa, R., Caspar, C.B., Van Beckhoven, A. and Levy, R. (2002) "Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma", Cancer Res. 62, 5845–5852.
   PubMed Web of Science ®Google Scholar